Northern Biologics Overview
- Year Founded
-
2014
- Status
-
Acquired/Merged
- Employees
-
21
- Latest Deal Type
-
M&A
- Investors
-
1
Northern Biologics General Information
Description
Developer of therapeutic antibodies intended to modify the tumor microenvironment in targeted patient populations. The company's therapeutic antibodies use antibody repertoires to develop functional modulators of key signaling pathways in cancer and fibrosis, enabling patients to get personalized cancer treatments.
Contact Information
Website
www.northernbiologics.comCorporate Office
- 101 College Street
- TMDT 11-301
- Toronto, Ontario M5G 1L7
- Canada
Corporate Office
- 101 College Street
- TMDT 11-301
- Toronto, Ontario M5G 1L7
- Canada
Northern Biologics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Merger/Acquisition | 14-May-2020 | Completed | Clinical Trials - Phase 1 | |||
| 5. Later Stage VC (Series B) | 15-Jun-2019 | Completed | Clinical Trials - Phase 1 | |||
| 4. Early Stage VC (Series A) | 15-Jun-2016 | Completed | Clinical Trials - Phase 1 | |||
| 3. Early Stage VC | 29-Apr-2015 | Completed | Clinical Trials - Phase 1 | |||
| 2. Early Stage VC (Series A) | 01-Oct-2014 | $10M | $10M | Completed | Clinical Trials - Phase 1 | |
| 1. Accelerator/Incubator | 01-Jun-2014 | Completed | Clinical Trials - Phase 1 |
Northern Biologics Comparisons
Industry
Financing
Details
Northern Biologics Competitors (111)
One of Northern Biologics’s 111 competitors is NexImmune, a Formerly VC-backed company based in Gaithersburg, MD.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| NexImmune | Formerly VC-backed | Gaithersburg, MD | ||||
| Aurora Biopharma | Angel-Backed | Cambridge, MA | ||||
| AsherBio | Venture Capital-Backed | South San Francisco, CA | ||||
| Macomics | Venture Capital-Backed | Edinburgh, United Kingdom | ||||
| Cogent Biosciences | Formerly VC-backed | Waltham, MA |
Northern Biologics Patents
Northern Biologics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-11390670-B2 | Antibodies against lif and uses thereof | Active | 03-Mar-2017 | ||
| US-20190352389-A1 | Antibodies against lif and uses thereof | Active | 03-Mar-2017 |
Northern Biologics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Northern Biologics Former Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Blueline Bioscience | Accelerator/Incubator | Minority | ||
| Caixa Capital Risc | Venture Capital | Minority | ||
| Celgene | Corporation | Minority | ||
| Northleaf Capital Partners | PE/Buyout | Minority | ||
| Sixty Degree Capital | Venture Capital | Minority |
Northern Biologics Acquisitions (1)
Northern Biologics’s most recent deal was a Merger/Acquisition with Mosaic Biomedicals. The deal was made on 19-Dec-2016.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Mosaic Biomedicals | 19-Dec-2016 | Merger/Acquisition | Other Healthcare Services |
Northern Biologics FAQs
-
When was Northern Biologics founded?
Northern Biologics was founded in 2014.
-
Where is Northern Biologics headquartered?
Northern Biologics is headquartered in Toronto, Canada.
-
What is the size of Northern Biologics?
Northern Biologics has 21 total employees.
-
What industry is Northern Biologics in?
Northern Biologics’s primary industry is Drug Discovery.
-
Is Northern Biologics a private or public company?
Northern Biologics is a Private company.
-
What is Northern Biologics’s current revenue?
The current revenue for Northern Biologics is .
-
How much funding has Northern Biologics raised over time?
Northern Biologics has raised $40M.
-
Who are Northern Biologics’s investors?
Blueline Bioscience, Caixa Capital Risc, Celgene, Northleaf Capital Partners, and Sixty Degree Capital are 5 of 8 investors who have invested in Northern Biologics.
-
Who are Northern Biologics’s competitors?
NexImmune, Aurora Biopharma, AsherBio, Macomics, and Cogent Biosciences are some of the 111 competitors of Northern Biologics.
-
When was Northern Biologics acquired?
Northern Biologics was acquired on 14-May-2020.
-
Who acquired Northern Biologics?
Northern Biologics was acquired by Boehringer Ingelheim.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
